Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; Controlled Randomized Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 45
- 试验地点
- 2
- 主要终点
- Change in Beck Depression Inventory (BDI) Scores
研究概览
简要总结
Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study.
Principal Investigator: Dr. Metin Çınaroğlu, Istanbul Nişantaşı University, Department of Psychology.
Study Duration: October, 2023 - Ongoing.
Objective: The study aims to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Ericksonian Hypnotherapy in alleviating symptoms of depression and anxiety among volunteers in Istanbul.
Methods: This randomized controlled trial will enroll healthy individuals aged 18-65 who exhibit symptoms of depression and anxiety but are not clinically diagnosed. Participants will be randomly divided into three groups: one receiving CBT, another receiving Ericksonian Hypnotherapy, and a control group receiving no therapeutic intervention. Standard psychological assessment tools such as the Beck Depression Inventory and Beck Anxiety Inventory will be used to measure outcomes.
Significance: Depression and anxiety are prevalent psychological disorders that significantly impair quality of life. Comparing these two therapeutic approaches may provide valuable insights into more effective psychological treatment strategies, thereby enhancing patient care in mental health settings.
Study Protocol:
Recruitment: 150 volunteers will be screened using socio-demographic forms and psychological assessments.
Intervention: Participants will undergo CBT or Ericksonian Hypnotherapy according to their group allocation, while the control group will be observed without intervention.
Evaluation: Pre- and post-treatment assessments will gauge the therapy's impact on depression and anxiety symptoms.
Expected Outcome: The study expects to demonstrate the relative efficacy of CBT and Ericksonian Hypnotherapy, providing evidence to guide treatment choices for managing depression and anxiety symptoms.
详细描述
Study Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study.
Principal Investigator: Dr. Metin Çınaroğlu, Associate Professor, Department of Psychology, Istanbul Nişantaşı University.
Co-Investigators:
Expert Psychologist Dr. Eda Yılmazer, Department of Psychology, Beykoz University.
Psychologist Cemre Odabaşı, Clinical Psychology (Thesis) Student, Istanbul Nişantaşı University.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age: Participants must be between 18 and 65 years old.
- •Symptoms: Participants must display symptoms of depression and/or anxiety, but not necessarily have a clinical diagnosis.
- •Voluntary Participation: Participants must voluntarily agree to participate and must be able to provide informed consent.
- •Residency: Participants must reside in or near the study location (Istanbul) to attend in-person sessions.
- •Language: Participants must be proficient in the language in which the therapy is delivered (presumably Turkish).
- •Availability: Participants must be available to attend all scheduled sessions over the course of the study (12 weekly sessions).
排除标准
- •Psychiatric Diagnosis: Individuals with a severe psychiatric disorder requiring immediate or intensive intervention (e.g., schizophrenia, bipolar disorder, or severe depression with suicidal ideation).
- •Current Psychotherapy: Individuals currently receiving other forms of psychotherapy or psychological treatment.
- •Substance Abuse: Individuals with active substance abuse issues or dependencies that could interfere with therapy.
- •Cognitive Impairments: Individuals with cognitive impairments or neurological disorders that would limit their ability to participate fully in therapy.
- •Medical Conditions: Individuals with severe medical conditions that could interfere with participation in the study or pose a risk during the therapy sessions.
- •Language Barrier: Non-Turkish speakers or those who do not understand the language well enough to benefit from therapy conducted in Turkish.
- •Previous Participation: Individuals who have previously participated in similar studies or interventions, to avoid potential biases in responses and outcomes.
研究组 & 干预措施
Cognitive Behavioral Therapy (CBT) Group
Participants in this group will receive Cognitive Behavioral Therapy, which involves identifying and modifying negative thought patterns and behaviors to alleviate symptoms of depression and anxiety. Therapy sessions are conducted in person and on a one-on-one basis, ensuring tailored and direct therapeutic engagement. Each participant will attend 12 weekly sessions, each lasting approximately one hour.
干预措施: Cognitive Behavioral Therapy (Behavioral)
Ericksonian Hypnotherapy Group
This group will receive Ericksonian Hypnotherapy, a therapeutic approach that utilizes techniques of hypnosis and suggestion to access and alter subconscious processes, aiming to reduce psychological distress associated with depression and anxiety. Similar to the CBT group, sessions are delivered in person on a one-on-one basis, with a total of 12 weekly sessions, each one hour long.
干预措施: Ericksonian Hypnotehrapy (Behavioral)
Control Group
Participants in this group will not receive any active intervention during the study period. This group serves as a control to measure the natural progression of depression and anxiety symptoms without therapeutic intervention. Participants will be monitored throughout the study and will be offered therapeutic sessions after the study's conclusion as compensation for their participation.
结局指标
主要结局
Change in Beck Depression Inventory (BDI) Scores
时间窗: Baseline and 12 weeks post-intervention
This outcome measures the change in depression levels among participants, as assessed by the Beck Depression Inventory. The BDI is a 21-item self-reported inventory that rates the severity of depression symptoms such as sadness, pessimism, sense of failure, and satisfaction in life, among others. The primary measure will be the difference in scores from baseline (pre-intervention) to post-intervention, indicating the efficacy of Cognitive Behavioral Therapy and Ericksonian Hypnotherapy in reducing depressive symptoms.
Change in Beck Anxiety Inventory (BAI) Scores
时间窗: Baseline and 12 weeks post-intervention
This outcome measures the change in anxiety levels, assessed using the Beck Anxiety Inventory. The BAI is a 21-item self-reported scale that evaluates the severity of anxiety symptoms, including nervousness, fear, and physiological responses related to anxiety. The main focus will be on the difference in scores from baseline to after the completion of the interventions, showcasing the impact of the therapeutic approaches on anxiety reduction.
次要结局
未报告次要终点
研究者
Metin Çınaroğlu
Asistant Professor
Istanbul Nisantasi University